Decreasing mortality from non-Hodgkin lymphoma in Australia

Internal Medicine Journal
M Coory, D Gill

Abstract

Based on the number of new cases (incidence), non-Hodgkin lymphoma is an increasingly common cancer in Australia and many developed countries. Until recently, mortality trends have been stable or slightly increasing. However, since the year 2000, mortality has decreased every year by an average of 5.1% per year (95% confidence interval (CI) -7.1 to -3.1%), whereas incidence has continued to increase at 0.9% per year (95%CI 0.6 to 1.2%). It was not possible with the population-based registry data available to us to untangle the causes of the decrease in mortality. The stable mortality rates during the 1990s (in the face of increasing incidence) might have been because of introduction of novel therapies such as autologous stem cell transplant for relapsed diffuse large cell lymphoma or the purine analogue-based therapy for indolent lymphomas. A plausible explanation for the large decrease in mortality since 2000 is the introduction of the monoclonal antibody rituximab.

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jan 29, 2000·Statistics in Medicine·H J KimD N Midthune
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Apr 9, 2002·Current Biology : CB·Joel H Rothman
Jan 28, 2004·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Christina A ClarkeElizabeth A Holly
May 6, 2004·Blood·Philippe Solal-CélignyEmili Montserrat
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnJoseph M Connors
Apr 29, 2006·Acta Oncologica·Karin Ekström-Smedby
Dec 1, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Peter AdamsonEve Roman
Apr 4, 2007·International Journal of Cancer. Journal International Du Cancer·Dominik D AlexanderDimitrios Trichopoulos

❮ Previous
Next ❯

Citations

Jan 15, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Laura P ForsytheJulia H Rowland
Nov 4, 2009·Acta Oto-laryngologica·Kasper AanaesLena Specht
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea K NgLois B Travis
Oct 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Malcolm Anthony Moore
Aug 3, 2011·Cadernos de saúde pública·Laércio Lima Luz, Inês Echenique Mattos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.